U.S. Transportation Stock News

Pebblebrook Hotel Trust stock moves draw investor focus Pebblebrook Hotel Trust (PEB) is back on many investors’ radars after a recent stretch of positive share price performance, with the stock up over the past month and past 3 months. See our latest analysis for Pebblebrook Hotel Trust. That recent upswing fits into a broader recovery story, with a 30 day share price return of 13.88% and a 1 year total shareholder return of 53.71% pointing to improving momentum despite a weak 5 year total...

Why Chemours stock is on investors’ radar Chemours (CC) has drawn fresh attention after its first quarter 2026 earnings, where several business segments outperformed expectations, and management highlighted debt reduction, refinancing activity, and reaffirmed full year sales and EBITDA guidance. See our latest analysis for Chemours. That interest has come against a sharp pullback in recent days, with a 1 day share price return of 5.32% decline and a 7 day share price return of 16.85% decline,...

Stepan Company reported past first-quarter 2026 results showing sales of US$604.51 million versus US$593.26 million a year earlier, but it swung from net income of US$19.71 million to a net loss of US$41.41 million, with basic and diluted loss per share from continuing operations of US$1.81 compared with earnings of US$0.86. Despite the move into loss-making territory, Stepan maintained its shareholder payout by affirming a quarterly dividend of US$0.395 per share, payable on June 15, 2026,...

Doximity (DOCS) is back in focus after its share price reacted to shifting analyst forecasts ahead of the upcoming earnings release, with investors weighing expectations for lower EPS against modest revenue growth. See our latest analysis for Doximity. The stock has staged a short term rebound, with a 7 day share price return of 6.51% and a 30 day share price return of 15.69%. However, this sits against a year to date share price return decline of 39.87% and a 1 year total shareholder return...

In April 2026, Seacoast Banking Corporation of Florida reported first-quarter 2026 results, with net interest income rising to US$176.47 million from US$118.52 million a year earlier, while net income was broadly flat at US$31.9 million and diluted EPS from continuing operations eased to US$0.29 from US$0.37. Over the same quarter, Seacoast also completed a buyback of 317,628 shares for US$10.23 million, a small but clear signal of ongoing capital return alongside its mixed earnings...

IHS Holding (NYSE:IHS) has completed the divestment of its 51% stake in Brazilian fiber infrastructure venture I-Systems. The stake has been sold to TIM S.A., marking IHS Holding's exit from this Brazilian optical fiber joint venture. IHS Holding, trading at $8.23, has seen its stock return 12.0% year to date and 44.1% over the past year, while its 3 year return stands at 9.2%. This completed I-Systems divestment gives investors a fresh development to consider alongside those share price...

If you are wondering whether Merit Medical Systems is starting to look interesting at its current share price, this article focuses squarely on what that price might imply about value. The stock last closed at US$62.33, with recent returns of an 8.6% decline over 7 days, a 7.5% decline over 30 days, a 27.9% decline year to date, and a 35.1% decline over the past year. These moves have put the stock back on many watchlists, as investors reassess what they are willing to pay for medical...

Jabil (JBL) is back in focus as investors look ahead to its upcoming earnings report, with expectations for higher earnings per share and revenue helping to fuel fresh interest in the stock. See our latest analysis for Jabil. The recent 1-day share price return of -6.11% to US$349.60 comes after a 30-day share price return of 28.13% and a 1-year total shareholder return of 126.78%. This points to strong momentum with some short term volatility as investors position around earnings...

Albemarle (NYSE:ALB) held its annual shareholder meeting on May 5, 2026. Shareholders approved the board slate, executive compensation package, and auditor ratification. A proposal to remove supermajority provisions for certain affiliated transactions narrowly did not pass. Shareholders backed a proposal to make it easier for investors to call special meetings. Albemarle, a major producer in the lithium and specialty chemicals space, sits at the center of debates around corporate governance...

In the first quarter of 2026, Live Nation Entertainment reported sales of US$3,793.03 million, but a net loss of US$389.1 million as a US$450 million legal accrual tied to investigations and litigation pushed the company into an operating loss. At the same time, the long-running Popp v. Live Nation and Ticketmaster nationwide class action over allegedly supracompetitive ticketing fees advanced, while management emphasized double-digit adjusted operating income growth expectations and record...

Encompass Health (EHC) stock is in focus after first quarter 2026 results topped Wall Street expectations, management raised full year revenue and adjusted EPS guidance, and the company continued expanding its inpatient rehabilitation hospital network. See our latest analysis for Encompass Health. The recent 1 day share price return of 2.0% to $107.15 and 7 day share price return of 7.2% suggest momentum has picked up following the earnings beat, higher guidance, new hospital opening and...

In recent days, LTX, an AI-powered corporate bond e-trading venue backed by Broadridge, announced that J.P. Morgan joined as a fully integrated liquidity provider, while JPMorgan Chase expanded its fixed-income issuance, rolled out new youth-focused banking tools, and deepened partnerships in data, private credit and tokenized settlement. Together, these moves highlight JPMorgan’s push to shape next-generation bond and digital markets even as CEO Jamie Dimon publicly flags risks of a...

Assessing US Foods Holding after recent returns Without a single defining news headline, US Foods Holding (USFD) has still drawn attention after recent share performance, with the stock showing a 5.6% decline over the past day and a 7.1% slide over the past week. Those short term moves sit alongside a smaller month pullback of 2.8% and a 3 month decline of 3.8%. The stock remains up 16.4% year to date and 20.9% over the past year. See our latest analysis for US Foods Holding. The recent 1 day...

Wondering if Maximus stock is offering fair value or a potential bargain right now, especially after a tough stretch for returns. The share price last closed at US$66.66, with Maximus delivering a 1.6% return over the past week and 2.3% over the last month, but a 22.9% decline year to date and a 10.6% decline over the last year hint at changing sentiment. Recent coverage has focused on how Maximus fits into investors' long term portfolios and whether the current price reflects its...

RenaissanceRe Holdings (NYSE:RNR) has appointed Henry Klehm III as Non-Executive Chair, succeeding the company’s long-serving board leader. The board also renewed its share repurchase program, authorizing up to $750 million of buybacks. These moves highlight changes in board oversight and capital allocation at a time when the stock trades around $300.84. RenaissanceRe Holdings comes into this leadership change with the stock at $300.84 and multi year share price gains, including 10.5% year...

If you are wondering whether DNOW stock offers value at today’s price, the key question is how that price lines up with the company’s underlying fundamentals. The stock last closed at US$13.05, with returns of 6.3% over 30 days, a 3.3% decline over 7 days, a 2.3% decline year to date, and a 10.2% decline over 1 year. The 3 year and 5 year returns sit at 43.1% and 19.8% respectively. These mixed returns highlight that sentiment around DNOW can shift over different time frames. This often...

Wondering if KKR at around US$100 per share is starting to look like value or if the stock still prices in a lot of optimism? This article walks through that question with a clear focus on what you are paying versus what you are getting. KKR has recently seen a 10.6% return over the last 30 days, even as year to date returns sit at 22.2% in the red and the 1 year return is a 15.0% loss, on top of a very large 111.1% gain over 3 years and 90.0% over 5 years. These mixed returns come against a...

If you are wondering whether Dynex Capital's current share price offers good value or carries more risk than reward, the starting point is to look closely at how it stacks up on valuation. The stock recently closed at US$13.32, with a 7 day return of 2.2% decline, a 30 day return of 5.0%, a year to date return of 5.4% decline, and a 1 year return of 25.5%, which gives you a mix of short term setbacks and longer term gains to weigh up. Recent coverage around Dynex Capital has focused on how...

In early May 2026, Voyager Technologies, Inc. reported first-quarter sales of US$35.25 million, a net loss of US$43.98 million, and raised its full-year 2026 revenue guidance to a range of US$230 million to US$255 million, supported by a record US$275 million backlog and new defense contracts. The company is also funding new technology development while actively seeking accretive acquisitions, aiming to enhance scale, margins and its overall position across missile defense and commercial...

In early May 2026, Alarm.com Holdings reported first-quarter revenue of US$265.19 million, up from US$238.82 million a year earlier, while GAAP net income eased to US$23.58 million and diluted earnings per share from continuing operations moved to US$0.47 from US$0.52. Alongside raising its full-year 2026 outlook, the company highlighted double-digit SaaS and license revenue growth, new AI-driven video analytics features, and a US$150 million share repurchase authorization, underscoring...

Dolby Laboratories, Inc. recently reported its second-quarter fiscal 2026 results, with revenue of US$395.63 million and net income of US$94.92 million, and issued third-quarter and full-year 2026 guidance alongside confirming a quarterly dividend of US$0.36 per share and progress on its long-running share repurchase program. An interesting detail is that since the buyback’s initiation in 2009, Dolby has retired over 54.33 million shares for about US$3.16 billion, materially shrinking its...

Why Grab’s Q1 earnings matter for shareholders Grab Holdings (GRAB) reported first quarter 2026 revenue of US$955 million and net income of US$136 million, both higher than a year earlier, with earnings surpassing analyst expectations and indicating improved operational efficiency. See our latest analysis for Grab Holdings. The Q1 beat and updates on AI products, autonomous rides and financial services come against a mixed share price backdrop, with a 6.5% 1 month share price return but a...

ACADIA Pharmaceuticals (ACAD) is back in focus after first quarter 2026 results showed 10% year over year revenue growth to US$268.1 million, alongside weaker earnings, higher expenses, and a setback for trofinetide in Europe. See our latest analysis for ACADIA Pharmaceuticals. The mixed Q1 2026 update, together with the negative EU opinion on trofinetide and leadership changes in research and development, appears to be feeding into a share price that has struggled year to date despite a...

Xeris Biopharma Holdings (XERS) stock is in focus after the company reported a profitable first quarter of 2026 and raised its full year revenue guidance to US$380 million to US$390 million. See our latest analysis for Xeris Biopharma Holdings. The guidance hike and first quarter profit have come after a mixed period for the stock, with a 12.95% 1 month share price return and a 9.80% year to date share price decline. At the same time, 1 year and 3 year total shareholder returns of 28.49% and...